Anu R. Neerukonda

Anu Neerukonda practices at The University of Chicago Medical Center in Chicago, Illinois.

Anu Neerukonda's NPI, 1619234218, was assigned on April 19, 2012. Anu Neerukonda holds Illinois license 036139877.

Anu Neerukonda's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Anu Neerukonda's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Anu Neerukonda is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Anu Neerukonda to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Anu Neerukonda practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Anu Neerukonda's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Anu Neerukonda is licensed in Illinois.

CMS data shows 728 Medicare services from Anu Neerukonda across 7 procedure codes in 2024, for 179 Medicare patients. Medicare paid $85,009 for them.

CMS counts 179 Medicare patients who saw Anu Neerukonda in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anu Neerukonda's median patient age at 70, with 65% women.

In 2024, Anu Neerukonda wrote 523 Medicare Part D claims for 105 patients. 72% of them were for generic drugs. CMS names the drug for 307 of them, across 15 drugs with 11 or more claims each, at $327,635 in total drug cost. In 2023, CMS named 328 claims across 14 drugs.

Anu Neerukonda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Anu Neerukonda as offering telehealth.

CMS Open Payments shows 9 general payments to Anu Neerukonda from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $237. It also lists 1 research payment totaling $1,750 in 2020.